Pathophysiology · MU Sofia

92. Anemias - definition, etiology, classification, pathomorphology, pathogenesis, compensatory mechanisms, clinical manifestations.

Inside: 1 section · 2 tables · 16 flashcards · 2 min

Topic 92 of 168 in the MU Sofia syllabus for Pathophysiology (Medicine, Year 3). The free AceMed note covers it in 1 section, about 300 words (2 min of reading), with 16 flashcards.

In this note

  1. Anemias - definition, etiology, classification, pathomorphology, pathogenesis, compensatory mechanisms, and clinical manifestations

Anemias - definition, etiology, classification, pathomorphology, pathogenesis, compensatory mechanisms, and clinical manifestations

Anemia is a condition characterized by decreased total red blood cell (RBC) mass, resulting in reduced hemoglobin concentration, hematocrit, and oxygen-carrying capacity of blood.

  • WHO definition:
  • Hb <13 g/dL in men.
  • Hb <12 g/dL in women.

Etiology

  1. 1 Decreased RBC production
  • Nutritional deficiencies:
  • Iron deficiency.
  • Vitamin B12 or folate deficiency.
  • Bone marrow failure:
  • Aplastic anemia.
  • Myelodysplastic syndromes.
  • Chronic diseases:
  • Chronic infections, chronic kidney disease (↓ erythropoietin).
  1. 2 Increased RBC destruction (hemolysis)
  • Intrinsic defects:
  • Membrane defects (hereditary spherocytosis).
  • Enzyme defects (G6PD deficiency).
  • Hemoglobinopathies (sickle cell anemia, thalassemia).
  • Extrinsic factors:
  • Autoimmune hemolytic anemia.
  • Mechanical trauma (prosthetic valves).
  1. 3 Blood loss
  • Acute hemorrhage (trauma, surgery).
  • Chronic bleeding (GI ulcers, heavy menstruation).

Classification

By morphology (MCV)

By pathogenesis

Pathomorphology

  • Bone marrow
  • Hypercellularity in hemolytic anemias (erythroid hyperplasia).
  • Hypocellularity in aplastic anemia.
  • Megaloblastic changes in B12/folate deficiency (large abnormal erythroid precursors).
  • Peripheral blood smear
  • Microcytosis, hypochromia (iron deficiency).
  • Macroovalocytes, hypersegmented neutrophils (megaloblastic anemia).
  • Spherocytes (hereditary spherocytosis).
  • Schistocytes (fragmented cells, microangiopathic hemolytic anemia).
  • Other organs
  • Extramedullary hematopoiesis (liver, spleen) in severe chronic anemias.
  • Iron overload (secondary hemosiderosis) in chronic hemolysis or multiple transfusions.
  • Pathogenesis
  1. Reduced oxygen-carrying capacity → tissue hypoxia.
  2. Activation of compensatory mechanisms (see below).
  3. Depending on cause: iron depletion, ineffective erythropoiesis, or increased RBC destruction.

Compensatory mechanisms

  • Increased cardiac output → tachycardia, palpitations.
  • Increased erythropoietin production → marrow hyperplasia.
  • Redistribution of blood flow → preferential perfusion of vital organs.
  • Increased 2,3-BPG in RBCs → enhanced oxygen release to tissues.

Clinical manifestation s

General (due to hypoxia)

  • Fatigue, weakness.
  • Dyspnea on exertion.
  • Dizziness, headache.
  • Palpitations.

Skin and mucous membranes

  • Pallor (skin, conjunctivae, mucosa).

Cardiovascular

  • Tachycardia.
  • Flow murmurs.
  • Possible heart failure in severe cases.

Specific signs (by type)

  • Iron deficiency anemia: koilonychia (spoon nails), glossitis, angular cheilitis, pica.
  • Megaloblastic anemia: smooth red tongue, neurological symptoms (paresthesias, ataxia) in B12 deficiency.
  • Hemolytic anemia: jaundice, dark urine, splenomegaly.

Read the full note free

The whole note is free with an AceMed account, with its 16 flashcards. Premium adds flashcard recall, highlights and Ask AI.